XML 59 R36.htm IDEA: XBRL DOCUMENT v3.25.2
Fair Value Measurements (Details) - Schedule of fair value assets measured on a recurring basis - USD ($)
$ in Thousands
Mar. 31, 2025
Dec. 31, 2024
Oct. 08, 2024
Dec. 31, 2023
Dec. 31, 2022
Liabilities:          
Oramed Note $ 14,962 $ 12,161   $ 104,089  
Convertible debenture       $ 4,340  
Tranche B Notes 24,480 23,560 $ 42,740    
Purchased revenue liability $ 7,300 $ 6,800 $ 5,900    
Derivative Liability, Statement of Financial Position [Extensible Enumeration] Derivative Liability, Noncurrent Derivative Liability, Noncurrent   Derivative Liability, Noncurrent  
Derivative liabilities $ 7,894 $ 18,303   $ 1,518  
Other long-term liabilities 155 155   179  
Total liabilities measured at fair value 54,791 60,979   110,126  
Level 1 [Member]          
Liabilities:          
Oramed Note 0 0   0  
Convertible debenture       0  
Tranche B Notes 0 0      
Purchased revenue liability 0 0      
Derivative liabilities 0 0   0  
Other long-term liabilities 0 0   0  
Total liabilities measured at fair value 0 0   0  
Level 2 [Member]          
Liabilities:          
Oramed Note 0 0   0  
Convertible debenture       0  
Tranche B Notes 0 0      
Purchased revenue liability 0 0      
Derivative liabilities 0 0   0  
Other long-term liabilities 0 0   0  
Total liabilities measured at fair value 0 0   0  
Level 3 [Member]          
Liabilities:          
Oramed Note 14,962 12,161   104,089  
Convertible debenture       4,340  
Tranche B Notes 24,480 23,560      
Purchased revenue liability 7,300 6,800      
Derivative liabilities 7,894 18,303   1,518 $ 1,231
Other long-term liabilities 155 155   179  
Total liabilities measured at fair value $ 54,791 $ 60,979   $ 110,126